Covaxin booster can neutralise Omicron, Delta variants: Bharat Biotech

Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta variants of COVID-19. Image used for representational......

Delhi govt vs Bharat Biotech over Covaxin supply

Deputy Chief Minister Manish Sisodia on Wednesday said Covaxin maker Bharat Biotech has refused to provide "additional" vaccine doses to the Delhi government, a development that is likely to......

Vaccine trials: Bharat Biotech recruits 23,000 volunteers

Bharat Biotech has recruited 23,000 volunteers and continued to progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of its COVID-19 vaccine Covaxin across multiple......

Bharat Biotech's Krishna Ella wins Covaxin fight

'He came back from the US only to work for his country.''He has invested his fortunes to build this company and is married to his work.''Rarely does one see such commitment.'Sohini Das reported.......

What's behind Bharat Biotech's Zika 'hype'?

Bharat Biotech started work on developing a vaccine against Zika way back in 2014, but the timing of its announcement has created a flutter in the market. When Bharat Biotech recently......

Bharat Biotech starts Covaxin's at-risk manufacture

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech  ......

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

India’s pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25......

India set to be global clinical trials hub

India is emerging as a major hub for global clinical trials and this new sector is poised to generate more revenue than the information technology industry by 2010, an industry leader has......